JP5259143B2 - Antibacterial agent - Google Patents
Antibacterial agent Download PDFInfo
- Publication number
- JP5259143B2 JP5259143B2 JP2007232650A JP2007232650A JP5259143B2 JP 5259143 B2 JP5259143 B2 JP 5259143B2 JP 2007232650 A JP2007232650 A JP 2007232650A JP 2007232650 A JP2007232650 A JP 2007232650A JP 5259143 B2 JP5259143 B2 JP 5259143B2
- Authority
- JP
- Japan
- Prior art keywords
- antibacterial
- antibacterial agent
- component
- bis
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003242 anti bacterial agent Substances 0.000 title claims description 55
- 230000000844 anti-bacterial effect Effects 0.000 claims description 33
- 229910021645 metal ion Inorganic materials 0.000 claims description 33
- -1 nitrogen-containing cyclic compound Chemical class 0.000 claims description 32
- 150000002484 inorganic compounds Chemical class 0.000 claims description 11
- 229910010272 inorganic material Inorganic materials 0.000 claims description 11
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 claims description 8
- 230000000845 anti-microbial effect Effects 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 8
- 239000007795 chemical reaction product Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 32
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 24
- 239000007864 aqueous solution Substances 0.000 description 19
- 239000000843 powder Substances 0.000 description 14
- 238000002845 discoloration Methods 0.000 description 13
- 239000002609 medium Substances 0.000 description 13
- 238000002156 mixing Methods 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 12
- 229910001961 silver nitrate Inorganic materials 0.000 description 12
- 239000010457 zeolite Substances 0.000 description 12
- 229910021536 Zeolite Inorganic materials 0.000 description 11
- 239000012153 distilled water Substances 0.000 description 11
- 238000011156 evaluation Methods 0.000 description 11
- 239000000463 material Substances 0.000 description 10
- 229910052709 silver Inorganic materials 0.000 description 10
- 239000004332 silver Substances 0.000 description 10
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
- 239000003973 paint Substances 0.000 description 9
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 239000002131 composite material Substances 0.000 description 8
- 239000000123 paper Substances 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000012298 atmosphere Substances 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- 239000006185 dispersion Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 229910000365 copper sulfate Inorganic materials 0.000 description 6
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 229910001431 copper ion Inorganic materials 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 239000010454 slate Substances 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000002270 dispersing agent Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 150000003335 secondary amines Chemical class 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 150000003512 tertiary amines Chemical class 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 2
- MTAYYBKXNAEQOK-UHFFFAOYSA-N 5-(2h-tetrazol-5-yl)-2h-tetrazole Chemical compound N1N=NC(C2=NNN=N2)=N1 MTAYYBKXNAEQOK-UHFFFAOYSA-N 0.000 description 2
- XZGLNCKSNVGDNX-UHFFFAOYSA-N 5-methyl-2h-tetrazole Chemical compound CC=1N=NNN=1 XZGLNCKSNVGDNX-UHFFFAOYSA-N 0.000 description 2
- MARUHZGHZWCEQU-UHFFFAOYSA-N 5-phenyl-2h-tetrazole Chemical compound C1=CC=CC=C1C1=NNN=N1 MARUHZGHZWCEQU-UHFFFAOYSA-N 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 2
- 239000004606 Fillers/Extenders Substances 0.000 description 2
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000001877 deodorizing effect Effects 0.000 description 2
- JYIMWRSJCRRYNK-UHFFFAOYSA-N dialuminum;disodium;oxygen(2-);silicon(4+);hydrate Chemical compound O.[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Na+].[Na+].[Al+3].[Al+3].[Si+4] JYIMWRSJCRRYNK-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 150000002736 metal compounds Chemical class 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 239000003021 water soluble solvent Substances 0.000 description 2
- 239000012463 white pigment Substances 0.000 description 2
- LEHFSLREWWMLPU-UHFFFAOYSA-B zirconium(4+);tetraphosphate Chemical compound [Zr+4].[Zr+4].[Zr+4].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LEHFSLREWWMLPU-UHFFFAOYSA-B 0.000 description 2
- KOVNXYJOKSNDJA-UHFFFAOYSA-N 1,2-bis(2h-tetrazol-5-yl)hydrazine Chemical compound N1=NNN=C1NNC=1N=NNN=1 KOVNXYJOKSNDJA-UHFFFAOYSA-N 0.000 description 1
- ZPPDPNQDTZPAER-UHFFFAOYSA-N 5-(2h-tetrazol-5-ylmethyl)-2h-tetrazole Chemical compound N1=NNN=C1CC=1N=NNN=1 ZPPDPNQDTZPAER-UHFFFAOYSA-N 0.000 description 1
- GJNTWVASQGUIOY-UHFFFAOYSA-N 5-[2-[2-(2h-tetrazol-5-yl)ethoxy]ethyl]-2h-tetrazole Chemical compound N1=NNN=C1CCOCCC=1N=NNN=1 GJNTWVASQGUIOY-UHFFFAOYSA-N 0.000 description 1
- JUWKXYNFODBPTJ-UHFFFAOYSA-N 5-[3-(2h-tetrazol-5-yl)phenyl]-2h-tetrazole Chemical compound C=1C=CC(C2=NNN=N2)=CC=1C=1N=NNN=1 JUWKXYNFODBPTJ-UHFFFAOYSA-N 0.000 description 1
- HFEJGPOJWWISRP-UHFFFAOYSA-N 5-[4-(2h-tetrazol-5-yl)but-2-enyl]-2h-tetrazole Chemical compound N1=NNN=C1CC=CCC=1N=NNN=1 HFEJGPOJWWISRP-UHFFFAOYSA-N 0.000 description 1
- CXQSAFJKCHJMQV-UHFFFAOYSA-N 5-[4-(2h-tetrazol-5-yl)butyl]-2h-tetrazole Chemical compound N1=NNN=C1CCCCC=1N=NNN=1 CXQSAFJKCHJMQV-UHFFFAOYSA-N 0.000 description 1
- TUSPQFBMQKZVAL-UHFFFAOYSA-N 5-[4-(2h-tetrazol-5-yl)phenyl]-2h-tetrazole Chemical compound C1=CC(C2=NNN=N2)=CC=C1C=1N=NNN=1 TUSPQFBMQKZVAL-UHFFFAOYSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical class [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- WJFCSZGMLZKYQT-UHFFFAOYSA-N N-(2H-tetrazol-5-yldiazenyl)-2H-tetrazol-5-amine Chemical compound N(N=Nc1nnn[nH]1)c1nnn[nH]1 WJFCSZGMLZKYQT-UHFFFAOYSA-N 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- JYIBXUUINYLWLR-UHFFFAOYSA-N aluminum;calcium;potassium;silicon;sodium;trihydrate Chemical compound O.O.O.[Na].[Al].[Si].[K].[Ca] JYIBXUUINYLWLR-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- JGZAFSFVZSXXCJ-UHFFFAOYSA-N bis(2H-tetrazol-5-yl)diazene Chemical compound N=1N=NNC=1N=NC1=NN=NN1 JGZAFSFVZSXXCJ-UHFFFAOYSA-N 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 239000004566 building material Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 229910001603 clinoptilolite Inorganic materials 0.000 description 1
- 239000004567 concrete Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- GDVKFRBCXAPAQJ-UHFFFAOYSA-A dialuminum;hexamagnesium;carbonate;hexadecahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-]C([O-])=O GDVKFRBCXAPAQJ-UHFFFAOYSA-A 0.000 description 1
- NJLLQSBAHIKGKF-UHFFFAOYSA-N dipotassium dioxido(oxo)titanium Chemical compound [K+].[K+].[O-][Ti]([O-])=O NJLLQSBAHIKGKF-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229910052675 erionite Inorganic materials 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 229910001701 hydrotalcite Inorganic materials 0.000 description 1
- 229960001545 hydrotalcite Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052680 mordenite Inorganic materials 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 239000003566 sealing material Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000013077 target material Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- JUWGUJSXVOBPHP-UHFFFAOYSA-B titanium(4+);tetraphosphate Chemical compound [Ti+4].[Ti+4].[Ti+4].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O JUWGUJSXVOBPHP-UHFFFAOYSA-B 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- 229910000166 zirconium phosphate Inorganic materials 0.000 description 1
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
本発明は、耐変色性に優れた抗菌剤に関するものである。 The present invention relates to an antibacterial agent having excellent discoloration resistance.
近年、MRSA(メチシリン耐性黄色ブトウ球菌)等による院内感染や、O−157(病原性大腸菌)等を原因とする食中毒の発生が問題視されるようになってきており、清潔志向や安全志向が高まっている。このような背景のもと、細菌感染や微生物汚染を防止する目的で、種々の抗菌剤が利用されている。抗菌剤は、一般に有機系抗菌剤と無機系抗菌剤に大別されるが、最近では無機系抗菌剤が注目されている。これは、無機系抗菌剤が、有機系抗菌剤に比べ、薬剤の安定性、人体に対する安全性等に優れ、環境配慮の観点においても望ましいためである。さらに、無機系抗菌剤は、抗菌効果の持続性においても優れた効果が期待できるものである。無機系抗菌剤は、銀、銅、亜鉛、ヒ素、鉛等の抗菌性金属イオンを活性種とするものであり、これらは古くから利用されている。この中でも銀イオンは、安全性や抗菌スペクトルの広さから、最も注目を浴びている。 In recent years, nosocomial infections caused by MRSA (methicillin-resistant Staphylococcus aureus) and food poisoning caused by O-157 (pathogenic Escherichia coli) have come to be regarded as problems. It is growing. Under such a background, various antibacterial agents are used for the purpose of preventing bacterial infection and microbial contamination. Antibacterial agents are generally roughly classified into organic antibacterial agents and inorganic antibacterial agents. Recently, inorganic antibacterial agents have attracted attention. This is because inorganic antibacterial agents are superior to organic antibacterial agents in terms of drug stability, safety to the human body, and the like, and are desirable from the viewpoint of environmental considerations. Furthermore, the inorganic antibacterial agent can be expected to have an excellent effect in the sustainability of the antibacterial effect. Inorganic antibacterial agents have antibacterial metal ions such as silver, copper, zinc, arsenic and lead as active species, and these have been used for a long time. Among these, silver ions are attracting the most attention because of their safety and the wide antibacterial spectrum.
しかし、銀イオン等の抗菌性金属イオンは、熱や光に曝露されることで還元され、変色を引き起こすことが知られている。このような変色を抑制する技術として、ゼオライトやリン酸ジルコニウム塩等の無機質担体に銀イオンを担持させる手法(特開昭64−24860号公報、特開2000−143420号公報等)、イミダゾール、ウラシル等の含窒素環状化合物や、チオール基含有有機化合物と銀イオンとを反応させる手法(特開平11−246213号公報、特開2004−224735号公報、特開2002−308708号公報等)等が提案されている。
しかしながら、これらの手法で得られた抗菌剤では、媒体中で抗菌性金属イオンが溶出して変色が生じたり、あるいは光に対する安定性が不十分であるために変色が生じる等の問題があり、長期安定性の点においては未だ課題が残されている状況である。
However, it is known that antibacterial metal ions such as silver ions are reduced by exposure to heat or light and cause discoloration. As a technique for suppressing such discoloration, a method of supporting silver ions on an inorganic carrier such as zeolite or zirconium phosphate salt (JP-A Nos. 64-24860 and 2000-143420), imidazole, uracil, etc. Such as nitrogen-containing cyclic compounds such as thiol group-containing organic compounds and silver ions (JP-A Nos. 11-246213, 2004-224735, 2002-308708, etc.) are proposed. Has been.
However, antibacterial agents obtained by these methods have problems such as antibacterial metal ions eluting in the medium and causing discoloration, or discoloration due to insufficient stability to light, There is still a problem in terms of long-term stability.
本発明は、このような問題点に鑑みなされたものであり、長期にわたり変色を抑制することができる抗菌剤を提供することを目的とするものである。 This invention is made | formed in view of such a problem, and it aims at providing the antibacterial agent which can suppress discoloration over a long term.
本発明者は、上記目的を達成するため鋭意検討を行った結果、抗菌性金属イオン(a)、当該抗菌性金属イオンの担体となり得る無機化合物(b)、及び含窒素環状化合物のビス体(c)を必須成分として含む抗菌剤に想到し、本発明を完成させるに到った。 As a result of intensive studies to achieve the above object, the present inventor has found that an antibacterial metal ion (a), an inorganic compound (b) that can serve as a carrier for the antibacterial metal ion, and a bis-form of a nitrogen-containing cyclic compound ( An antibacterial agent containing c) as an essential component was conceived and the present invention was completed.
すなわち、本発明は以下の特徴を有するものである。
1.抗菌性金属イオン(a)、当該抗菌性金属イオンの担体となり得る無機化合物(b)、及び含窒素環状化合物のビス体(c)を含み、
前記抗菌性金属イオン(a)が銀イオン、前記含窒素環状化合物のビス体(c)がビステトラゾール化合物であることを特徴とする抗菌剤。
2.抗菌性金属イオン(a)と含窒素環状化合物のビス体(c)との反応生成物が、当該抗菌性金属イオンの担体となり得る無機化合物(b)に担持されてなり、
前記抗菌性金属イオン(a)が銀イオン、前記含窒素環状化合物のビス体(c)がビステトラゾール化合物であることを特徴とする抗菌剤。
3.抗菌性金属イオン(a)、当該抗菌性金属イオンの担体となり得る無機化合物(b)、含窒素環状化合物のビス体(c)、及び媒体(d)を含み、
前記抗菌性金属イオン(a)が銀イオン、前記含窒素環状化合物のビス体(c)がビステトラゾール化合物であることを特徴とする抗菌剤。
That is, the present invention has the following characteristics.
1. Antibacterial metal ions (a), the inorganic compound which can be a carrier of the antimicrobial metal ions (b), and bis-a (c) viewed free nitrogen-containing cyclic compound,
An antibacterial agent, wherein the antibacterial metal ion (a) is a silver ion, and the bis-form (c) of the nitrogen-containing cyclic compound is a bistetrazole compound .
2. Reaction products of antimicrobial metal ions (a) and bis-nitrogen-containing cyclic compound (c) is, Ri Na is supported on an inorganic compound which can be a carrier of the antimicrobial metal ions (b),
An antibacterial agent, wherein the antibacterial metal ion (a) is a silver ion, and the bis-form (c) of the nitrogen-containing cyclic compound is a bistetrazole compound .
3. Antibacterial metal ions (a), the inorganic compound which can be a carrier of the antimicrobial metal ions (b), bis-nitrogen-containing cyclic compound (c), and viewed including the medium (d),
An antibacterial agent, wherein the antibacterial metal ion (a) is a silver ion, and the bis-form (c) of the nitrogen-containing cyclic compound is a bistetrazole compound.
本発明によれば、抗菌性金属イオンに起因する変色を抑制することができ、長期にわたる色安定性を確保することができる。 According to the present invention, discoloration caused by antibacterial metal ions can be suppressed, and long-term color stability can be ensured.
以下、本発明を実施するための最良の形態について説明する。 Hereinafter, the best mode for carrying out the present invention will be described.
本発明の抗菌剤は、抗菌性金属イオン(a)、当該抗菌性金属イオンの担体となり得る無機化合物(b)、及び含窒素環状化合物のビス体(c)を必須成分として含む抗菌剤である。 The antibacterial agent of the present invention is an antibacterial agent comprising an antibacterial metal ion (a), an inorganic compound (b) that can serve as a carrier for the antibacterial metal ion, and a bis-form (c) of a nitrogen-containing cyclic compound as essential components. .
このうち、抗菌性金属イオン(a)(以下「(a)成分」ともいう)としては、例えば、銀イオン、銅イオン、亜鉛イオン等が挙げられ、この中でも特に銀イオンが好適である。このような(a)成分は、例えば、抗菌性金属イオンの硝酸塩、硫酸塩、塩化物等の金属塩により得ることができる。 Among these, examples of the antibacterial metal ions (a) (hereinafter also referred to as “component (a)”) include silver ions, copper ions, zinc ions, and the like, and among these, silver ions are particularly preferable. Such component (a) can be obtained, for example, from metal salts such as nitrates, sulfates and chlorides of antibacterial metal ions.
抗菌性金属イオンの担体となり得る無機化合物(b)(以下「(b)成分」ともいう)は、(a)成分の瞬時の溶出を抑制し、抗菌効果を持続させる役割等を担うものである。このような(b)成分は、(a)成分をイオン交換反応、物理吸着または化学吸着により担持可能なものであればよい。
具体的に(b)成分としては、例えば、活性炭、活性アルミナ、シリカゲル、ゼオライト、ヒドロキシアパタイト、リン酸ジルコニウム、リン酸チタン、チタン酸カリウム、含水酸化ビスマス、含水酸化ジルコニウム、ハイドロタルサイト等が挙げられる。本発明では、この中でも特にゼオライトが好適である。ゼオライトとしては、例えば、チャバサイト、モルデナイト、エリオナイト、クリノプチロライト等の天然ゼオライト、A型ゼオライト、X型ゼオライト、Y型ゼオライト等の合成ゼオライトが挙げられ、これらの1種または2種以上を使用することができる。このような(b)成分の粒子径は、通常0.01〜100μm程度である。
The inorganic compound (b) (hereinafter also referred to as “component (b)”) that can serve as a carrier for antibacterial metal ions plays a role of suppressing instantaneous elution of the component (a) and maintaining the antibacterial effect. . Such (b) component should just be what can support (a) component by ion exchange reaction, physical adsorption, or chemical adsorption.
Specific examples of the component (b) include activated carbon, activated alumina, silica gel, zeolite, hydroxyapatite, zirconium phosphate, titanium phosphate, potassium titanate, hydrous bismuth, hydrous zirconium, hydrotalcite, and the like. It is done. Of these, zeolite is particularly preferred in the present invention. Examples of the zeolite include natural zeolites such as chabasite, mordenite, erionite, and clinoptilolite, and synthetic zeolites such as A-type zeolite, X-type zeolite, and Y-type zeolite. Can be used. The particle size of such component (b) is usually about 0.01 to 100 μm.
含窒素環状化合物のビス体(以下「(c)成分」ともいう)は、含窒素環状構造を1分子内に2つ有する対称的な化学構造を有するものである。本発明では、含窒素環状化合物のこのような特異的な化学構造により、抗菌剤中の金属イオンの安定性が高まり、変色抑制の効果が得られるものと考えられる。
含窒素環状化合物のビス体としては、ビステトラゾール化合物が好ましく、例えば、5,5′‐ビ(1H‐テトラゾール)、5,5′‐メチレンビス(2H‐テトラゾール)、5,5′‐アゾビス(1H‐テトラゾール)、5,5′‐ジアゾアミノビス(1H‐テトラゾール)、5,5′‐(2‐ブテン‐1,4‐ジイル)ビス(1H‐テトラゾール)、5,5′‐(1,4‐フェニレン)ビス(2H‐テトラゾール)、5,5′‐(1,3‐フェニレン)ビス(2H‐テトラゾール)、5,5′‐テトラメチレンビス(2H‐テトラゾール)、1,2‐ビス(1H‐テトラゾール‐5‐イル)ヒドラジン、5,5′‐(オキシビスエチレン)ビス(1H‐テトラゾール)、4,5‐ビス(1H‐テトラゾール‐5‐イル)‐2H‐イミダゾール、ビス(1H‐テトラゾール‐5‐イル)アミン、及びこれらの誘導体(ナトリウム塩、アンモニウム塩等の塩等)が挙げられる。
The bis-form of the nitrogen-containing cyclic compound (hereinafter also referred to as “component (c)”) has a symmetric chemical structure having two nitrogen-containing cyclic structures in one molecule. In the present invention, such a specific chemical structure of the nitrogen-containing cyclic compound is considered to increase the stability of the metal ions in the antibacterial agent and obtain the effect of suppressing discoloration.
The bis-form of the nitrogen-containing cyclic compound is preferably a bistetrazole compound, such as 5,5'-bi (1H-tetrazole), 5,5'-methylenebis (2H-tetrazole), 5,5'-azobis (1H -Tetrazole), 5,5'-diazoaminobis (1H-tetrazole), 5,5 '-(2-butene-1,4-diyl) bis (1H-tetrazole), 5,5'-(1,4 -Phenylene) bis (2H-tetrazole), 5,5 '-(1,3-phenylene) bis (2H-tetrazole), 5,5'-tetramethylenebis (2H-tetrazole), 1,2-bis (1H -Tetrazol-5-yl) hydrazine, 5,5 '-(oxybisethylene) bis (1H-tetrazole), 4,5-bis (1H-tetrazol-5-yl) -2H-imidazo Le, bis (1H-tetrazol-5-yl) amine, and their derivatives (sodium salts, salts such as ammonium salts, etc.).
含窒素環状化合物のビス体における含窒素環状構造には、第2級アミンと第3級アミンが混在することが望ましい。このような化合物を用いた場合には、その対称的な化学構造に加え、第2級アミンにより生じるイオンと、第3級アミンが有するローンペアとの複合的作用により、耐変色性等においてより優れた効果が発揮されるものと推察される。本発明における含窒素環状化合物のビス体としては、特に5,5′‐ビ(1H‐テトラゾール)(「ビステトラゾール」ともいう)及びその誘導体が好適である。 It is desirable that a secondary amine and a tertiary amine are mixed in the nitrogen-containing cyclic structure in the bis body of the nitrogen-containing cyclic compound. When such a compound is used, in addition to its symmetric chemical structure, due to the combined action of ions generated by secondary amines and loan pairs possessed by tertiary amines, discoloration resistance and the like are further improved. It is presumed that an excellent effect is exhibited. As the bis-form of the nitrogen-containing cyclic compound in the present invention, 5,5′-bi (1H-tetrazole) (also referred to as “bistetrazole”) and its derivatives are particularly suitable.
(a)成分と(c)成分の比率は、抗菌性金属イオンの価数と取り得る配位数、含窒素環状化合物のビス体に含まれる第2級アミン及び第3級アミンの数等にもよるが、概ねモル比で2:1〜1:4程度である。
また本発明では、(a)成分と(c)成分の合計量が(b)成分の0.001〜20重量%の範囲であることが望ましく、0.01〜10重量%の範囲にあることがより望ましい。
The ratio of the component (a) to the component (c) depends on the valence of the antibacterial metal ion and the possible coordination number, the number of secondary amines and tertiary amines contained in the bis-form of the nitrogen-containing cyclic compound, etc. Although it depends, the molar ratio is about 2: 1 to 1: 4.
In the present invention, the total amount of the component (a) and the component (c) is desirably in the range of 0.001 to 20% by weight of the component (b), and in the range of 0.01 to 10% by weight. Is more desirable.
本発明の抗菌剤は、粉状または液状の形態とすることができる。このうち、粉状の形態としては、(a)成分と(c)成分との反応生成物が、(b)成分に担持されてなるものが好適である。 The antibacterial agent of the present invention can be in the form of powder or liquid. Among these, as the powdery form, a product in which a reaction product of the component (a) and the component (c) is supported on the component (b) is preferable.
このような粉状の形態において、(a)成分と(c)成分との反応生成物(以下単に「反応生成物」ともいう。)を(b)成分に担持させる方法としては、公知の方法を用いればよく、例えばイオン交換反応により担持させる方法、物理吸着または化学吸着により担持させる方法等が挙げられる。このほか、結合剤により担持させる方法、金属化合物を無機化合物に打ち込むことにより担持させる方法、蒸着、溶解析出反応、スパッタ等の薄膜形成法により無機化合物の表面に金属化合物の薄層を形成させることにより担持させる方法等を採用することもできる。 In such a powdery form, a known method is a method for supporting the reaction product of component (a) and component (c) (hereinafter also simply referred to as “reaction product”) on component (b). May be used, and examples thereof include a method of supporting by ion exchange reaction and a method of supporting by physical adsorption or chemical adsorption. In addition, a thin layer of a metal compound is formed on the surface of the inorganic compound by a method of supporting by a binder, a method of supporting a metal compound by implanting it into an inorganic compound, a thin film forming method such as vapor deposition, dissolution and precipitation reaction, and sputtering. It is also possible to adopt a method of carrying by the above.
具体的に、粉状の抗菌剤は、(a)成分の塩を含む水溶液と、(c)成分を含む水溶液とを混合して反応させた後、(b)を混合して反応生成物を吸着させ、次いでろ過、洗浄、乾燥する方法等により製造することができる。この際、各水溶液のpH、濃度等は適宜設定することができる。(a)成分の塩としては、抗菌性金属イオンの硝酸塩、硫酸塩、塩化物等を使用することができる。また、乾燥工程の後に、必要に応じ粉砕等の操作を行うこともできる。最終的に得られる粉末の粒子径は、概ね0.01〜100μm程度に調整すればよい。 Specifically, the powdered antibacterial agent is prepared by mixing and reacting an aqueous solution containing the salt of the component (a) and an aqueous solution containing the component (c), and then mixing the reaction product of (b). It can be produced by a method of adsorbing, followed by filtration, washing, drying and the like. At this time, the pH, concentration and the like of each aqueous solution can be appropriately set. As the salt of the component (a), an antibacterial metal ion nitrate, sulfate, chloride or the like can be used. In addition, after the drying step, operations such as pulverization can be performed as necessary. What is necessary is just to adjust the particle diameter of the powder finally obtained to about 0.01-100 micrometers.
液状の形態については、媒体(d)(以下「(d)成分」ともいう)に、(a)成分、(b)成分、及び(c)成分が含まれるものであればよい。この液状の形態において、(a)成分は(b)成分に担持された状態であることが望ましい。(c)成分については、(a)成分とともに(b)成分に担持された状態であってもよいし、(b)成分とは別に媒体(d)に溶解ないし分散した状態であってもよい。 Any liquid form may be used as long as the medium (d) (hereinafter also referred to as “component (d)”) includes the component (a), the component (b), and the component (c). In this liquid form, the component (a) is desirably supported on the component (b). The component (c) may be in a state of being supported on the component (b) together with the component (a), or may be dissolved or dispersed in the medium (d) separately from the component (b). .
媒体(d)は、上記(a)〜(c)成分を溶解ないし分散する作用を有するものである。本発明における(d)成分としては、水を必須成分とし、必要に応じその他の水溶性溶剤等を含む水系媒体が好適である。このうち水溶性溶剤としては、例えば、アルコール類、グリコール類、グリコールエーテル類等が挙げられる。(d)成分は、増粘剤、pH調整剤、分散剤、防腐剤、消泡剤等の各種添加剤を含むものであってもよい。
このような液状の形態においては、(a)成分、(b)成分及び(c)成分の合計量が1〜80重量%、(d)成分が20〜99重量%となるように調製すればよい。
The medium (d) has an action of dissolving or dispersing the components (a) to (c). As the component (d) in the present invention, an aqueous medium containing water as an essential component and containing other water-soluble solvent or the like as appropriate is suitable. Among these, examples of the water-soluble solvent include alcohols, glycols, glycol ethers and the like. (D) A component may contain various additives, such as a thickener, a pH adjuster, a dispersing agent, antiseptic | preservative, and an antifoamer.
In such a liquid form, if the total amount of the component (a), the component (b) and the component (c) is 1 to 80% by weight, and the component (d) is 20 to 99% by weight, Good.
液状の形態においては、上記(a)〜(d)成分を必須成分として含むものである限り、その製造方法は特に限定されるものではない。具体的な製造方法の一例としては、抗菌性金属イオンの塩を含む水溶液に(b)成分を混合して、(b)成分に(a)成分を担持させた後、ろ過、洗浄して(a)成分と(b)成分の複合物を得、含窒素環状化合物のビス体の塩を含む水溶液に、この複合物を分散させる方法等が挙げられる。この際、各水溶液のpH、濃度等は適宜設定することができ、必要に応じ各種添加剤を混合することもできる。 In the liquid form, the production method is not particularly limited as long as the components (a) to (d) are included as essential components. As an example of a specific production method, the component (b) is mixed with an aqueous solution containing an antibacterial metal ion salt, the component (b) is supported on the component (b), and then filtered and washed ( Examples thereof include a method in which a composite of component a) and component (b) is obtained, and the composite is dispersed in an aqueous solution containing a bis salt of a nitrogen-containing cyclic compound. At this time, pH, concentration and the like of each aqueous solution can be appropriately set, and various additives can be mixed as necessary.
本発明の抗菌剤は、抗菌性が求められる各種材料に適用することができる。適用可能な材料としては、例えば、プラスチック、ゴム、接着剤、糊、塗料、インク、繊維、不織布、木材、建材、紙、合成紙、皮革、シーリング材、コンクリート、モルタル等が挙げられる。本発明の抗菌剤を、これら材料に含有させるには、対象となる材料の形態等を考慮して適宜方法を選定すればよい。具体的な方法としては、例えば、混合法、溶融混合法、含浸法、噴霧法、分散混合法等が挙げられる。抗菌剤の使用量は、材料の種類や用途等に応じ適宜設定すればよいが、各材料の100重量部に対し、通常0.001〜10重量部程度、より好ましくは、0.01〜5重量部程度である。本発明の抗菌剤は、上述のような材料に抗菌性を付与するとともに、防黴、消臭、脱臭、分解、浄化等の機能を付与することもできる。また、本発明の抗菌剤を水性塗料に用いた場合には、変色抑制効果が顕著となり好適である。この変色抑制効果については、pH、ハロゲン等の影響を受けにくいという利点もある。本発明の抗菌剤は、他の薬剤(有機系抗菌剤等)と併用することもできる。 The antibacterial agent of the present invention can be applied to various materials that require antibacterial properties. Examples of applicable materials include plastic, rubber, adhesive, glue, paint, ink, fiber, nonwoven fabric, wood, building material, paper, synthetic paper, leather, sealing material, concrete, and mortar. In order to incorporate the antibacterial agent of the present invention in these materials, an appropriate method may be selected in consideration of the form of the target material. Specific examples of the method include a mixing method, a melt mixing method, an impregnation method, a spray method, and a dispersion mixing method. The amount of the antibacterial agent used may be appropriately set according to the type and use of the material, but is usually about 0.001 to 10 parts by weight, more preferably 0.01 to 5 parts per 100 parts by weight of each material. About parts by weight. The antibacterial agent of the present invention can impart antibacterial properties to the materials as described above, and can also provide functions such as antifungal, deodorizing, deodorizing, decomposing, and purifying. In addition, when the antibacterial agent of the present invention is used for an aqueous paint, the discoloration suppressing effect is remarkable, which is preferable. This discoloration suppressing effect has an advantage that it is hardly affected by pH, halogen, and the like. The antibacterial agent of the present invention can be used in combination with other drugs (organic antibacterial agents and the like).
以下に実施例を示し、本発明の特徴をより明確にする。 Examples are given below to clarify the features of the present invention.
[I]試験例1
(実施例1−1)
蒸留水に硝酸銀を混合して0.1Mの硝酸銀水溶液を調製した。
一方、蒸留水にビステトラゾールジアンモニウムを混合し、水酸化ナトリウムでpHを11に調整して、0.2Mのビステトラゾール水溶液を調製した。
このようにして得られたビステトラゾール水溶液を硝酸銀水溶液に混合し(銀イオンとビステトラゾールのモル比1:1)、さらに銀イオン担持量が2重量%となるようにA型ゼオライト粉末(平均粒子径75μm)を混合して、3時間攪拌・分散した。次いで、この分散液をろ過し、水で洗浄した後、50℃雰囲気下で24時間乾燥させ、粉砕することにより粉状の抗菌剤1−Aを得た。
以上の方法で得られた抗菌剤につき、以下の各試験を行った。
[I] Test Example 1
(Example 1-1)
A 0.1M silver nitrate aqueous solution was prepared by mixing silver nitrate with distilled water.
On the other hand, bistetrazole diammonium was mixed with distilled water, and the pH was adjusted to 11 with sodium hydroxide to prepare a 0.2M bistetrazole aqueous solution.
The aqueous bistetrazole solution thus obtained was mixed with an aqueous silver nitrate solution (a molar ratio of silver ions to bistetrazole of 1: 1), and the A-type zeolite powder (average particle size) was adjusted so that the amount of silver ions supported was 2% by weight. The mixture was stirred and dispersed for 3 hours. Next, the dispersion was filtered, washed with water, dried in an atmosphere at 50 ° C. for 24 hours, and pulverized to obtain a powdery antibacterial agent 1-A.
The antimicrobial agents obtained by the above methods were subjected to the following tests.
(1)貯蔵安定性
アクリル樹脂エマルション200重量部に対し、白色顔料(二酸化チタン)130重量部、体質顔料(重質炭酸カルシウム)100重量部、分散剤5重量部、増粘剤5重量部、消泡剤2重量部、及び上記抗菌剤1−A5重量部を常法により均一に混合して水性塗料を作製した。
この水性塗料を、すきま150μmのフィルムアプリケータで白紙上に塗付し、遮光条件下、標準状態(温度23℃・相対湿度50%)で48時間乾燥して塗紙を得、塗紙の色を分光光度計により測定してL*1、a*1、b*1を算出した。
次に、水性塗料を容器に密封・遮光し、所定の温度(5℃、23℃、50℃)で50日間貯蔵した後、同様の方法で塗紙を作成して分光光度計による測定を行い、L*2、a*2、b*2を算出した。
以上の方法で得られた値より、貯蔵前後の色差(△E)を次式に従って算出した。評価基準は、◎:色差0.5未満、○:色差0.5以上1.0未満、△:色差1.0以上2.0未満、×:色差2.0以上、とした。
△E={(L*2−L*1)2+(a*2−a*1)2+(b*2−b*1)2}0.5
(1) Storage stability For 200 parts by weight of the acrylic resin emulsion, 130 parts by weight of white pigment (titanium dioxide), 100 parts by weight of extender pigment (heavy calcium carbonate), 5 parts by weight of dispersant, 5 parts by weight of thickener, A water-based paint was prepared by uniformly mixing 2 parts by weight of an antifoaming agent and 5 parts by weight of the antibacterial agent 1-A by a conventional method.
This water-based paint is applied on white paper with a film applicator with a clearance of 150 μm and dried for 48 hours under light-shielding conditions in a standard state (temperature 23 ° C., relative humidity 50%) to obtain a paper. Were measured with a spectrophotometer to calculate L * 1 , a * 1 , and b * 1 .
Next, the water-based paint is sealed in a container, shielded from light, and stored at a predetermined temperature (5 ° C, 23 ° C, 50 ° C) for 50 days, then a coated paper is prepared in the same manner and measured with a spectrophotometer. , L * 2 , a * 2 and b * 2 were calculated.
From the value obtained by the above method, the color difference (ΔE) before and after storage was calculated according to the following formula. Evaluation criteria were as follows: :: Color difference of less than 0.5, ◯: Color difference of 0.5 or more and less than 1.0, Δ: Color difference of 1.0 or more and less than 2.0, x: Color difference of 2.0 or more.
△ E = {(L * 2 -L * 1) 2 + (a * 2 -a * 1) 2 + (b * 2 -b * 1) 2} 0.5
(2)耐水性試験
予めシーラーが塗装されたスレート板に対し、上記(1)で作製した塗料を塗付量0.3kg/m2でスプレー塗装した後、遮光条件下、標準状態で14日間乾燥させたものを試験体とした。この試験体の色を分光光度計により測定してL*1、a*1、b*1を算出した。
次に、試験体を23℃の水に6時間浸漬した後、再度分光光度計により測定を行い、L*2、a*2、b*2を算出した。
以上の方法で得られた値より、水浸漬前後の色差を算出し、上記(1)と同様の評価基準により評価を行った。
(2) Water resistance test The slate plate previously coated with a sealer was spray-coated with the coating material prepared in (1) above at a coating amount of 0.3 kg / m 2 , and then in a standard condition under light-shielding conditions for 14 days. The dried sample was used as a test specimen. The color of this test body was measured with a spectrophotometer, and L * 1 , a * 1 , and b * 1 were calculated.
Next, after immersing a test body in 23 degreeC water for 6 hours, it measured by the spectrophotometer again, and calculated L * 2 , a * 2 , b * 2 .
From the value obtained by the above method, the color difference before and after the water immersion was calculated and evaluated according to the same evaluation criteria as in (1) above.
(3)耐光性試験
予めシーラーが塗装されたスレート板に対し、上記(1)で作製した塗料を塗付量0.3kg/m2でスプレー塗装した後、遮光条件下、標準状態で14日間乾燥させたものを試験体とした。この試験体の色を分光光度計により測定してL*1、a*1、b*1を算出した。
次に、この試験体表面に、22W蛍光灯を距離15cmで50日間照射した後、再度分光光度計により測定を行い、L*2、a*2、b*2を算出した。
以上の方法で得られた値より、照射前後の色差を算出し、上記(1)と同様の評価基準により評価を行った。
(3) Light resistance test A slate plate coated with a sealer in advance is spray-coated with the coating material prepared in (1) above at a coating amount of 0.3 kg / m 2 , and then under standard conditions under light-shielding conditions for 14 days. The dried sample was used as a test specimen. The color of this test body was measured with a spectrophotometer, and L * 1 , a * 1 , and b * 1 were calculated.
Next, the surface of the test specimen was irradiated with a 22 W fluorescent lamp at a distance of 15 cm for 50 days, and then again measured with a spectrophotometer to calculate L * 2 , a * 2 and b * 2 .
From the values obtained by the above method, the color difference before and after irradiation was calculated, and evaluation was performed according to the same evaluation criteria as in (1) above.
(4)抗菌性試験
抗菌性については、固体培地法による最小発育阻止濃度の評価を行った。
薬剤濃度が100μg/mlから6.5μg/mlになるように、2倍希釈系列希釈液を作製し、抗菌剤を滅菌処理した標準寒天培地で混釈し、これを冷却させ、寒天を固めたものを固体培地とした。一方、黄色ブドウ球菌を滅菌水に懸濁し、106CFU/mlの濃度の菌懸濁液を調製した。この菌懸濁液を、固体培地に無菌操作的に白金耳にて画線接種し、37℃に設定した培養器の中で、24時間培養を行った。培養後、培地に生育したコロニーが5個以下である固体培地の中で、最も薬剤濃度の低いものを最小発育濃度とした。
評価基準は、◎:500ppm未満、○:500ppm以上1000ppm未満、△:1000ppm以上2000ppm未満、×:2000ppm以上、とした。
(4) Antibacterial test For antibacterial activity, the minimum growth inhibitory concentration was evaluated by the solid medium method.
A 2-fold dilution series diluted solution was prepared so that the drug concentration was changed from 100 μg / ml to 6.5 μg / ml, and mixed with a standard agar medium sterilized with an antibacterial agent, which was cooled to harden the agar. The material was a solid medium. On the other hand, Staphylococcus aureus was suspended in sterile water to prepare a bacterial suspension having a concentration of 10 6 CFU / ml. This bacterial suspension was streaked into a solid medium aseptically with a platinum loop and cultured for 24 hours in an incubator set at 37 ° C. After culturing, among the solid media having 5 or less colonies grown on the media, the one with the lowest drug concentration was defined as the minimum growth concentration.
The evaluation criteria were as follows: ◎: less than 500 ppm, ◯: 500 ppm or more and less than 1000 ppm, Δ: 1000 ppm or more and less than 2000 ppm, ×: 2000 ppm or more.
試験結果を表1に示す。実施例1−1では、いずれの試験においても優れた結果を得ることができた。 The test results are shown in Table 1. In Example 1-1, excellent results could be obtained in any test.
(実施例1−2)
蒸留水に硫酸銅を混合して0.1Mの硫酸銅水溶液を調製した。
一方、蒸留水にビステトラゾールジアンモニウムを混合し、水酸化ナトリウムでpHを11に調整して、0.2Mのビステトラゾール水溶液を調製した。
このようにして得られたビステトラゾール水溶液を硫酸銅水溶液に混合し(銅イオンとビステトラゾールのモル比1:1)、さらに銅イオン担持量が2重量%となるようにA型ゼオライト粉末(平均粒子径75μm)を混合して、3時間攪拌した。次いで、この分散液をろ過し、水で洗浄した後、50℃雰囲気下で24時間乾燥させ、粉砕することにより粉状の抗菌剤1−Bを得た。
抗菌剤1−Bにつき、実施例1−1と同様の方法で各種試験を行った。試験結果を表1に示す。
(Example 1-2)
Copper sulfate was mixed with distilled water to prepare a 0.1 M aqueous copper sulfate solution.
On the other hand, bistetrazole diammonium was mixed with distilled water, and the pH was adjusted to 11 with sodium hydroxide to prepare a 0.2M bistetrazole aqueous solution.
The aqueous bistetrazole solution thus obtained was mixed with an aqueous copper sulfate solution (a molar ratio of copper ions to bistetrazole of 1: 1), and A type zeolite powder (average) so that the amount of copper ions supported was 2% by weight. Particle size 75 μm) was mixed and stirred for 3 hours. Next, this dispersion was filtered, washed with water, dried in an atmosphere at 50 ° C. for 24 hours, and pulverized to obtain a powdery antibacterial agent 1-B.
For antibacterial agent 1-B, various tests were conducted in the same manner as in Example 1-1. The test results are shown in Table 1.
(比較例1−1)
蒸留水に硝酸銀を混合して0.1Mの硝酸銀水溶液を調製した。
得られた硝酸銀水溶液に、銀イオン担持量が2重量%となるようにA型ゼオライト粉末(平均粒子径75μm)を混合して、3時間攪拌・分散した。次いで、この分散液をろ過し、水で洗浄した後、120℃雰囲気下で6時間乾燥させ、粉砕することにより粉状の抗菌剤1−Cを得た。
抗菌剤1−Cにつき、実施例1−1と同様の方法で各種試験を行った。試験結果を表1に示す。
(Comparative Example 1-1)
A 0.1M silver nitrate aqueous solution was prepared by mixing silver nitrate with distilled water.
The obtained aqueous silver nitrate solution was mixed with A-type zeolite powder (average particle size 75 μm) so that the supported amount of silver ions was 2% by weight, and stirred and dispersed for 3 hours. Next, this dispersion was filtered, washed with water, dried in an atmosphere at 120 ° C. for 6 hours, and pulverized to obtain a powdery antibacterial agent 1-C.
For antibacterial agent 1-C, various tests were conducted in the same manner as in Example 1-1. The test results are shown in Table 1.
(比較例1−2)
ビステトラゾールジアンモニウムに替えて1H−イミダゾールを使用した以外は、実施例1−1の方法に従い粉状の抗菌剤1−Dを得、各種試験を行った。試験結果を表1に示す。
(Comparative Example 1-2)
Except that 1H-imidazole was used instead of bistetrazole diammonium, a powdery antibacterial agent 1-D was obtained according to the method of Example 1-1, and various tests were performed. The test results are shown in Table 1.
(比較例1−3)
ビステトラゾールジアンモニウムに替えて5−フェニル−1H−テトラゾールを使用した以外は、実施例1−1の方法に従い粉状の抗菌剤1−Eを得、各種試験を行った。試験結果を表1に示す。
(Comparative Example 1-3)
Except that 5-phenyl-1H-tetrazole was used in place of bistetrazole diammonium, powdered antibacterial agent 1-E was obtained according to the method of Example 1-1, and various tests were performed. The test results are shown in Table 1.
(比較例1−4)
ビステトラゾールジアンモニウムに替えて5−メチル−1H−テトラゾールを使用した以外は、実施例1−1の方法に従い粉状の抗菌剤1−Fを得、各種試験を行った。試験結果を表1に示す。
(Comparative Example 1-4)
Except that 5-methyl-1H-tetrazole was used instead of bistetrazole diammonium, powdered antibacterial agent 1-F was obtained according to the method of Example 1-1, and various tests were performed. The test results are shown in Table 1.
[II]試験例2 [II] Test example 2
(実施例2−1)
蒸留水に硝酸銀を混合して0.1Mの硝酸銀水溶液を調製した。この硝酸銀水溶液に対し、A型ゼオライト粉末(平均粒子径75μm)を混合・分散して3時間攪拌し、次いでこの分散液をろ過し、水で洗浄した後、120℃雰囲気下で6時間乾燥させ、粉砕することにより複合粉末(銀イオン担持量2重量%)を得た。
一方、蒸留水にビステトラゾールジアンモニウムを混合し、水酸化ナトリウムでpHを11に調整して、0.2Mのビステトラゾール水溶液を調製した。
このビステトラゾール水溶液10gに対し、上記複合粉末10gを混合・分散することにより、液状(スラリー状)の抗菌剤2−Aを得た。
以上の方法で得られた抗菌剤につき、以下の各試験を行った。
(Example 2-1)
A 0.1M silver nitrate aqueous solution was prepared by mixing silver nitrate with distilled water. A type A zeolite powder (average particle size 75 μm) is mixed and dispersed in this silver nitrate aqueous solution and stirred for 3 hours. The dispersion is then filtered, washed with water, and dried in an atmosphere at 120 ° C. for 6 hours. By pulverizing, composite powder (silver ion loading amount 2% by weight) was obtained.
On the other hand, bistetrazole diammonium was mixed with distilled water, and the pH was adjusted to 11 with sodium hydroxide to prepare a 0.2M bistetrazole aqueous solution.
10 g of the composite powder was mixed and dispersed in 10 g of this bistetrazole aqueous solution to obtain a liquid (slurry) antibacterial agent 2-A.
The antimicrobial agents obtained by the above methods were subjected to the following tests.
(1)スラリーの外観変化
抗菌剤を容器に密封・遮光し、50℃雰囲気下で50日間貯蔵した後の外観を目視にて確認した。この試験では、変色が認められないものを「◎」、著しい変色が認められるものを「×」とする4段階(◎>○>△>×)で評価を行った。
(1) Change in appearance of slurry The antibacterial agent was sealed in a container, shielded from light, and the appearance after storage for 50 days in an atmosphere at 50 ° C. was visually confirmed. In this test, the evaluation was made in four stages (>>○>Δ> ×) where “◎” indicates no discoloration and “×” indicates no significant discoloration.
(2)貯蔵安定性
アクリル樹脂エマルション200重量部に対し、白色顔料(二酸化チタン)130重量部、体質顔料(重質炭酸カルシウム)100重量部、分散剤5重量部、増粘剤5重量部、消泡剤2重量部、及び上記抗菌剤2−A10重量部を常法により均一に混合して水性塗料を作製した。
この水性塗料を、すきま150μmのフィルムアプリケータで白紙上に塗付し、遮光条件下、標準状態(温度23℃・相対湿度50%)で48時間乾燥して塗紙を得、塗紙の色を分光光度計により測定してL*1、a*1、b*1を算出した。
次に、水性塗料を容器に密封・遮光し、所定の温度(5℃、23℃、50℃)で50日間貯蔵した後、同様の方法で塗紙を作成して分光光度計による測定を行い、L*2、a*2、b*2を算出した。
以上の方法で得られた値より、貯蔵前後の色差(△E)を次式に従って算出した。評価基準は、◎:色差0.5未満、○:色差0.5以上1.0未満、△:色差1.0以上2.0未満、×:色差2.0以上、とした。
△E={(L*2−L*1)2+(a*2−a*1)2+(b*2−b*1)2}0.5
(2) Storage stability For 200 parts by weight of acrylic resin emulsion, 130 parts by weight of white pigment (titanium dioxide), 100 parts by weight of extender pigment (heavy calcium carbonate), 5 parts by weight of dispersant, 5 parts by weight of thickener, A water-based paint was prepared by uniformly mixing 2 parts by weight of an antifoaming agent and 10 parts by weight of the antibacterial agent 2-A by a conventional method.
This water-based paint is applied on white paper with a film applicator with a clearance of 150 μm and dried for 48 hours under light-shielding conditions in a standard state (temperature 23 ° C., relative humidity 50%) to obtain a paper. Were measured with a spectrophotometer to calculate L * 1 , a * 1 , and b * 1 .
Next, the water-based paint is sealed in a container, shielded from light, and stored at a predetermined temperature (5 ° C, 23 ° C, 50 ° C) for 50 days, then a coated paper is prepared in the same manner and measured with a spectrophotometer. , L * 2 , a * 2 and b * 2 were calculated.
From the value obtained by the above method, the color difference (ΔE) before and after storage was calculated according to the following formula. Evaluation criteria were as follows: :: Color difference of less than 0.5, ◯: Color difference of 0.5 or more and less than 1.0, Δ: Color difference of 1.0 or more and less than 2.0, x: Color difference of 2.0 or more.
△ E = {(L * 2 -L * 1) 2 + (a * 2 -a * 1) 2 + (b * 2 -b * 1) 2} 0.5
(3)耐水性試験
予めシーラーが塗装されたスレート板に対し、上記(2)で作製した塗料を塗付量0.3kg/m2でスプレー塗装した後、遮光条件下、標準状態で14日間乾燥させたものを試験体とした。この試験体の色を分光光度計により測定してL*1、a*1、b*1を算出した。
次に、試験体を23℃の水に6時間浸漬した後、再度分光光度計により測定を行い、L*2、a*2、b*2を算出した。
以上の方法で得られた値より、水浸漬前後の色差を算出し、上記(2)と同様の評価基準により評価を行った。
(3) Water resistance test The slate plate previously coated with a sealer was spray-coated with the coating material prepared in (2) above at a coating amount of 0.3 kg / m 2 , and then under standard conditions under light-shielding conditions for 14 days. The dried sample was used as a test specimen. The color of this test body was measured with a spectrophotometer, and L * 1 , a * 1 , and b * 1 were calculated.
Next, after immersing a test body in 23 degreeC water for 6 hours, it measured by the spectrophotometer again, and calculated L * 2 , a * 2 , b * 2 .
From the value obtained by the above method, the color difference before and after water immersion was calculated and evaluated according to the same evaluation criteria as in (2) above.
(4)耐光性試験
予めシーラーが塗装されたスレート板に対し、上記(2)で作製した塗料を塗付量0.3kg/m2でスプレー塗装した後、遮光条件下、標準状態で14日間乾燥させたものを試験体とした。この試験体の色を分光光度計により測定してL*1、a*1、b*1を算出した。
次に、この試験体表面に、22W蛍光灯を距離15cmで50日間照射した後、再度分光光度計により測定を行い、L*2、a*2、b*2を算出した。
以上の方法で得られた値より、照射前後の色差を算出し、上記(2)と同様の評価基準により評価を行った。
(4) Light resistance test The paint prepared in (2) above was spray-coated at a coating amount of 0.3 kg / m 2 on a slate plate previously coated with a sealer, and then in a standard state under light-shielding conditions for 14 days. The dried sample was used as a test specimen. The color of this test body was measured with a spectrophotometer, and L * 1 , a * 1 , and b * 1 were calculated.
Next, the surface of the test specimen was irradiated with a 22 W fluorescent lamp at a distance of 15 cm for 50 days, and then again measured with a spectrophotometer to calculate L * 2 , a * 2 and b * 2 .
From the value obtained by the above method, the color difference before and after irradiation was calculated, and evaluation was performed according to the same evaluation criteria as in (2) above.
(5)抗菌性試験
抗菌性については、固体培地法による最小発育阻止濃度の評価を行った。
薬剤濃度が4000μg/mlから250μg/mlになるように、2倍希釈系列希釈液を作製し、抗菌剤を滅菌処理した標準寒天培地で混釈し、これを冷却させ、寒天を固めたものを固体培地とした。一方、黄色ブドウ球菌を滅菌水に懸濁し、106CFU/mlの濃度の菌懸濁液を調製した。この菌懸濁液を、固体培地に無菌操作的に白金耳にて画線接種し、37℃に設定した培養器の中で、24時間培養を行った。培養後、培地に生育したコロニーが5個以下である固体培地の中で、最も薬剤濃度の低いものを最小発育濃度とした。
評価基準は、◎:1000ppm未満、○:1000ppm以上2000ppm未満、△:2000ppm以上4000ppm未満、×:4000ppm以上、とした。
(5) Antibacterial test For antibacterial activity, the minimum growth inhibitory concentration was evaluated by the solid medium method.
Prepare a 2-fold dilution series dilution so that the drug concentration is from 4000 μg / ml to 250 μg / ml, pour it in a standard agar medium sterilized with an antibacterial agent, cool it, and harden the agar. A solid medium was used. On the other hand, Staphylococcus aureus was suspended in sterile water to prepare a bacterial suspension having a concentration of 10 6 CFU / ml. This bacterial suspension was streaked into a solid medium aseptically with a platinum loop and cultured for 24 hours in an incubator set at 37 ° C. After culturing, among the solid media having 5 or less colonies grown on the media, the one with the lowest drug concentration was defined as the minimum growth concentration.
The evaluation criteria were ◎: less than 1000 ppm, ◯: 1000 ppm or more and less than 2000 ppm, Δ: 2000 ppm or more and less than 4000 ppm, and x: 4000 ppm or more.
試験結果を表2に示す。実施例2−1では、いずれの試験においても優れた結果を得ることができた。 The test results are shown in Table 2. In Example 2-1, excellent results could be obtained in any test.
(実施例2−2)
蒸留水に硫酸銅を混合して0.1Mの硫酸銅水溶液を調製した。この硫酸銅水溶液に、A型ゼオライト粉末(平均粒子径75μm)を混合・分散して3時間攪拌し、次いでこの分散液をろ過し、水で洗浄した後、120℃雰囲気下で6時間乾燥させ、粉砕することにより複合粉末(銅イオン担持量2重量%)を得た。
一方、蒸留水にビステトラゾールジアンモニウムを混合し、水酸化ナトリウムでpHを11に調整して、0.2Mのビステトラゾール水溶液を調製した。
このビステトラゾール水溶液10gに対し、上記複合粉末10gを混合・分散することにより、液状(スラリー状)の抗菌剤2−Bを得た。
抗菌剤2−Aに替えて抗菌剤2−Bを用い、実施例2−1と同様の方法で各種試験を行った。試験結果を表2に示す。
(Example 2-2)
Copper sulfate was mixed with distilled water to prepare a 0.1 M aqueous copper sulfate solution. A type A zeolite powder (average particle size 75 μm) is mixed and dispersed in this copper sulfate aqueous solution and stirred for 3 hours. The dispersion is then filtered, washed with water, and dried in an atmosphere at 120 ° C. for 6 hours. By pulverizing, composite powder (copper ion carrying amount 2% by weight) was obtained.
On the other hand, bistetrazole diammonium was mixed with distilled water, and the pH was adjusted to 11 with sodium hydroxide to prepare a 0.2M bistetrazole aqueous solution.
A liquid (slurry) antibacterial agent 2-B was obtained by mixing and dispersing 10 g of the composite powder to 10 g of this bistetrazole aqueous solution.
Various tests were performed in the same manner as in Example 2-1, using the antibacterial agent 2-B instead of the antibacterial agent 2-A. The test results are shown in Table 2.
(比較例2−1)
蒸留水に硝酸銀を混合して0.1Mの硝酸銀水溶液を調製した。
得られた硝酸銀水溶液に、A型ゼオライト粉末(平均粒子径75μm)を混合・分散して、3時間攪拌した。次いで、この分散液をろ過し、水で洗浄した後、120℃雰囲気下で6時間乾燥させ、粉砕することにより複合粉末(銀イオン担持量2重量%)を得た。
この複合粉末10gを蒸留水10gに混合・分散することにより、抗菌剤2−Cを得た。
抗菌剤2−Aに替えて抗菌剤2−Cを用い、実施例2−1と同様の方法で各種試験を行った。試験結果を表2に示す。
(Comparative Example 2-1)
A 0.1M silver nitrate aqueous solution was prepared by mixing silver nitrate with distilled water.
A-type zeolite powder (average particle size 75 μm) was mixed and dispersed in the obtained silver nitrate aqueous solution and stirred for 3 hours. Next, this dispersion was filtered, washed with water, dried in an atmosphere at 120 ° C. for 6 hours, and pulverized to obtain a composite powder (silver ion loading 2% by weight).
Antibacterial agent 2-C was obtained by mixing and dispersing 10 g of this composite powder in 10 g of distilled water.
Various tests were conducted in the same manner as in Example 2-1, using the antibacterial agent 2-C instead of the antibacterial agent 2-A. The test results are shown in Table 2.
(比較例2−2)
ビステトラゾールジアンモニウムに替えて1H−イミダゾールを使用した以外は、実施例2−1の方法に従い抗菌剤2−Dを得、各種試験を行った。試験結果を表2に示す。
(Comparative Example 2-2)
Except for using 1H-imidazole instead of bistetrazole diammonium, antibacterial agent 2-D was obtained according to the method of Example 2-1, and various tests were performed. The test results are shown in Table 2.
(比較例2−3)
ビステトラゾールジアンモニウムに替えて5−フェニル−1H−テトラゾールを使用した以外は、実施例2−1の方法に従い抗菌剤2−Eを得、各種試験を行った。試験結果を表2に示す。
(Comparative Example 2-3)
Except for using 5-phenyl-1H-tetrazole instead of bistetrazole diammonium, antibacterial agent 2-E was obtained according to the method of Example 2-1, and various tests were performed. The test results are shown in Table 2.
(比較例2−4)
ビステトラゾールジアンモニウムに替えて5−メチル−1H−テトラゾールを使用した以外は、実施例2−1の方法に従い抗菌剤2−Fを得、各種試験を行った。試験結果を表2に示す。
(Comparative Example 2-4)
Except for using 5-methyl-1H-tetrazole instead of bistetrazole diammonium, antibacterial agent 2-F was obtained according to the method of Example 2-1, and various tests were performed. The test results are shown in Table 2.
Claims (3)
前記抗菌性金属イオン(a)が銀イオン、前記含窒素環状化合物のビス体(c)がビステトラゾール化合物であることを特徴とする抗菌剤。 Antibacterial metal ions (a), the inorganic compound which can be a carrier of the antimicrobial metal ions (b), and bis-a (c) viewed free nitrogen-containing cyclic compound,
An antibacterial agent, wherein the antibacterial metal ion (a) is a silver ion, and the bis-form (c) of the nitrogen-containing cyclic compound is a bistetrazole compound .
前記抗菌性金属イオン(a)が銀イオン、前記含窒素環状化合物のビス体(c)がビステトラゾール化合物であることを特徴とする抗菌剤。 Reaction products of antimicrobial metal ions (a) and bis-nitrogen-containing cyclic compound (c) is, Ri Na is supported on an inorganic compound which can be a carrier of the antimicrobial metal ions (b),
An antibacterial agent, wherein the antibacterial metal ion (a) is a silver ion, and the bis-form (c) of the nitrogen-containing cyclic compound is a bistetrazole compound .
前記抗菌性金属イオン(a)が銀イオン、前記含窒素環状化合物のビス体(c)がビステトラゾール化合物であることを特徴とする抗菌剤。
Antibacterial metal ions (a), the inorganic compound which can be a carrier of the antimicrobial metal ions (b), bis-nitrogen-containing cyclic compound (c), and viewed including the medium (d),
An antibacterial agent, wherein the antibacterial metal ion (a) is a silver ion, and the bis-form (c) of the nitrogen-containing cyclic compound is a bistetrazole compound .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007232650A JP5259143B2 (en) | 2006-09-07 | 2007-09-07 | Antibacterial agent |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006242775 | 2006-09-07 | ||
| JP2006242775 | 2006-09-07 | ||
| JP2006242776 | 2006-09-07 | ||
| JP2006242776 | 2006-09-07 | ||
| JP2007232650A JP5259143B2 (en) | 2006-09-07 | 2007-09-07 | Antibacterial agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008088169A JP2008088169A (en) | 2008-04-17 |
| JP5259143B2 true JP5259143B2 (en) | 2013-08-07 |
Family
ID=39372678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007232650A Expired - Fee Related JP5259143B2 (en) | 2006-09-07 | 2007-09-07 | Antibacterial agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5259143B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6160946B2 (en) * | 2013-03-06 | 2017-07-12 | 五洋建設株式会社 | Construction method of antibacterial concrete floor |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0629133B2 (en) * | 1989-10-31 | 1994-04-20 | 工業技術院長 | Antibacterial silver zeolite without discoloration and antibacterial polymer composition |
| JP2849017B2 (en) * | 1993-03-22 | 1999-01-20 | 帝人株式会社 | Manufacturing method of antibacterial fiber |
| JPH11246213A (en) * | 1998-03-02 | 1999-09-14 | Kanebo Ltd | Antibacterial composition |
| JP3328629B2 (en) * | 2000-02-25 | 2002-09-30 | 大塚化学株式会社 | Gypsum composition and molded article obtained therefrom having antibacterial and / or antifungal properties |
| JP2002308708A (en) * | 2001-04-12 | 2002-10-23 | Katayama Chem Works Co Ltd | Discoloration inhibitor for silver antimicrobial agent, silver antimicrobial agent comprising the same and antimicrobial method |
| JP4436050B2 (en) * | 2003-01-23 | 2010-03-24 | 株式会社シナネンゼオミック | Antibacterial composition |
| JP2005137601A (en) * | 2003-11-06 | 2005-06-02 | Polyplastics Co | Deodorant and deodorant resin composition |
| US7393395B2 (en) * | 2004-02-05 | 2008-07-01 | Nippon Mining & Metals Co., Ltd. | Surface-treating agent for metal |
| JP5121193B2 (en) * | 2006-09-07 | 2013-01-16 | エスケー化研株式会社 | Paint composition |
-
2007
- 2007-09-07 JP JP2007232650A patent/JP5259143B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008088169A (en) | 2008-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101023751B (en) | Antibacterial zeolite and antibacterial composition | |
| KR100765083B1 (en) | Ag-Containing Solution, Antibacterial Resin Composition Comprising the Solution and Antibacterial Resin Coated Steel Plate | |
| EP0288063A2 (en) | Antibiotic resin composition | |
| US9901094B2 (en) | Antibacterial resin composition | |
| JPH0428646B2 (en) | ||
| CA2621163A1 (en) | Synergetic silver-containing biocide composition | |
| CN101938900A (en) | Liquid composition containing histidine silver complex, bactericide composition and stabilization method of histidine silver complex | |
| JP5718092B2 (en) | Antibacterial, bactericidal or antiviral composition | |
| JP2026048863A (en) | Biocidal compositions and methods | |
| JP2821968B2 (en) | Mold-resistant waterproof coating | |
| JP2773286B2 (en) | Antibacterial agent | |
| JP5259143B2 (en) | Antibacterial agent | |
| EP1769680B1 (en) | Preparation for the fungicidal and algicidal finish of alkaline coating compositions | |
| CN113150591B (en) | Water-based paint in-tank preservative | |
| JP5121193B2 (en) | Paint composition | |
| JP5603701B2 (en) | Antibacterial composition and use thereof | |
| JP2012041287A (en) | Aqueous bactericide and antibacterial composition | |
| JP2802712B2 (en) | Anti-mold sealant | |
| JPS63221175A (en) | Painted walls and sprayed materials with antifungal and antibacterial properties | |
| JPH01164722A (en) | Weatherability antibacterial zeolite composition | |
| JP3140408B2 (en) | Antimicrobial agent | |
| JP4052526B2 (en) | Antibacterial resin | |
| JP2000247805A (en) | Inorganic composition having antibacterial and mildew resistant activity, and resin composition having the same activity | |
| JP7531046B1 (en) | Oil-based paint having antiviral, antifungal and antibacterial activity, including coronavirus, and method for disinfecting viruses, fungi and bacteria, including coronavirus | |
| JP3117383B2 (en) | Bactericidal and antifungal composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100818 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120814 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120906 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121024 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130415 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130424 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160502 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5259143 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |
